PlasmaGen Biosciences Competitors and Similar CompaniesClear all

PlasmaGen Biosciences's competitors and similar companies include Alexion Pharmaceuticals, Macopharma, Pharming Group and Amanta Healthcare.

	PlasmaGen Biosciences PlasmaGen BioSciences is a bio-pharmaceutical organization specializing in plasma protein therapy.	Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.	Macopharma Macopharma is a provider of blood transfusion and bio-sourced therapies.	Pharming Group Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.	Amanta Healthcare Amanta Healthcare is a company that manufactures sterile liquid parenterals.
Founding Date	Founding Date 2010	Founding Date 1992	Founding Date 1977	Founding Date 1988	Founding Date 1997
Type	Type Private	Type Public	Type Private	Type Public	Type Private
Tags	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy
Locations	Locations Bengaluru, IN HQ Bengaluru, IN	Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more	Locations Tourcoing, FR HQ Mouvaux, FR	Locations Leiden, NL HQ Leiden, NL	Locations Ahmedabad, IN HQ
Employees	Employees 4032% increase	Employees 10,6006% increase	Employees 901	Employees 404	Employees 3052% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 40.3 b	Valuation ($) N/A	Valuation ($) 590.3 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $6.1b (FY, 2020)	Revenue (est.) N/A	Revenue (est.) $376.1m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $553.5m (FY, 2020)	Cost of goods N/A	Cost of goods $41.6m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $5.5b (FY, 2020)	Gross profit N/A	Gross profit $341m (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income $603.4m (FY, 2020)	Net income N/A	Net income $2.5m (FY, 2025)	Net income N/A